Activating Compound | Comment | Organism | Structure |
---|---|---|---|
dithiothreitol | stimulates activity | Mycobacterium tuberculosis | |
Triton X-100 | detergent stimulates activity, maximally active in presence of 0.1% Triton X-100 | Mycobacterium tuberculosis |
Cloned (Comment) | Organism |
---|---|
expression in Escherichia coli | Mycobacterium tuberculosis |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.029 | - |
neryl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.04 | - |
geranylgeranyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.084 | - |
(2E,6E)-farnesyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.089 | - |
isopentenyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.29 | - |
(2Z,6E)-farnesyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.49 | - |
geranyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Ca2+ | absolute requirement for divalent cations. Enzyme activity is optimal in the presence of 1 mM Mg2+. MnCl2 at 0.1 mM also supports the activity. CaCl2 and ZnCl2 are much less effective | Mycobacterium tuberculosis | |
Mg2+ | absolute requirement for divalent cations. Enzyme activity is optimal in the presence of 1 mM Mg2+. MnCl2 at 0.1 mM also supports the activity. CaCl2 and ZnCl2 are much less effective | Mycobacterium tuberculosis | |
Mn2+ | absolute requirement for divalent cations. Enzyme activity is optimal in the presence of 1 mM Mg2+. MnCl2 at 0.1 mM also supports the activity. CaCl2 and ZnCl2 are much less effective | Mycobacterium tuberculosis | |
Zn2+ | absolute requirement for divalent cations. Enzyme activity is optimal in the presence of 1 mM Mg2+. MnCl2 at 0.1 mM also supports the activity. CaCl2 and ZnCl2 are much less effective | Mycobacterium tuberculosis |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
36000 | - |
x * 36000, SDS-PAGE | Mycobacterium tuberculosis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
(2Z,6E)-farnesyl diphosphate + 7 isopentenyl diphosphate | Mycobacterium tuberculosis | the catalytic efficiency is greatest when (2Z,6E)-farnesyl diphosphate is used as the allylic acceptor, suggesting that this is the natural substrate in vivo | 7 diphosphate + (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-decaprenyl diphosphate | - |
? | |
(2Z,6E)-farnesyl diphosphate + 7 isopentenyl diphosphate | Mycobacterium tuberculosis H37Rv | the catalytic efficiency is greatest when (2Z,6E)-farnesyl diphosphate is used as the allylic acceptor, suggesting that this is the natural substrate in vivo | 7 diphosphate + (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-decaprenyl diphosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | P9WFF7 | - |
- |
Mycobacterium tuberculosis H37Rv | P9WFF7 | - |
- |
Purification (Comment) | Organism |
---|---|
- |
Mycobacterium tuberculosis |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(2E,6E)-farnesyl diphosphate + isopentenyl diphosphate | - |
Mycobacterium tuberculosis | diphosphate + decaprenyl diphosphate + nonaprenyl diphosphate + octaprenyl diphosphate | the relative amounts of both decaprenyl diphosphate and octaprenyl diphosphate are greater than that of nonaprenyl diphosphate. Shorter chain length also produced. As the concentration of (2Z,6E)-farnesyl diphosphate is increased in the assays, there is an increase in the amount of the shorter products synthesized relative to decaprenyl diphosphate | ? | |
(2E,6E)-farnesyl diphosphate + isopentenyl diphosphate | - |
Mycobacterium tuberculosis H37Rv | diphosphate + decaprenyl diphosphate + nonaprenyl diphosphate + octaprenyl diphosphate | the relative amounts of both decaprenyl diphosphate and octaprenyl diphosphate are greater than that of nonaprenyl diphosphate. Shorter chain length also produced. As the concentration of (2Z,6E)-farnesyl diphosphate is increased in the assays, there is an increase in the amount of the shorter products synthesized relative to decaprenyl diphosphate | ? | |
(2Z,6E)-farnesyl diphosphate + 7 isopentenyl diphosphate | the catalytic efficiency is greatest when (2Z,6E)-farnesyl diphosphate is used as the allylic acceptor, suggesting that this is the natural substrate in vivo | Mycobacterium tuberculosis | 7 diphosphate + (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-decaprenyl diphosphate | - |
? | |
(2Z,6E)-farnesyl diphosphate + 7 isopentenyl diphosphate | (2Z,6E)-farnesyl diphosphate i.e. omega, E,Z-farnesyl diphosphate, the catalytic efficiency is greatest when (2Z,6E)-farnesyl diphosphate is used as the allylic acceptor | Mycobacterium tuberculosis | 7 diphosphate + (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-decaprenyl diphosphate | decaprenyl diphosphate is the predominant product synthesized, smaller amounts of intermediates of intermediates of shorter chain lengths also being produced. The amount of 40-carbon and 45-carbon products relative to 50-carbon products increases as the (2Z,6E)-farnesyl diphosphate concentration is increased, suggesting that the enzyme loses specificity as the substrate concentration increases | ? | |
(2Z,6E)-farnesyl diphosphate + 7 isopentenyl diphosphate | the catalytic efficiency is greatest when (2Z,6E)-farnesyl diphosphate is used as the allylic acceptor, suggesting that this is the natural substrate in vivo | Mycobacterium tuberculosis H37Rv | 7 diphosphate + (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-decaprenyl diphosphate | - |
? | |
(2Z,6E)-farnesyl diphosphate + 7 isopentenyl diphosphate | (2Z,6E)-farnesyl diphosphate i.e. omega, E,Z-farnesyl diphosphate, the catalytic efficiency is greatest when (2Z,6E)-farnesyl diphosphate is used as the allylic acceptor | Mycobacterium tuberculosis H37Rv | 7 diphosphate + (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-decaprenyl diphosphate | decaprenyl diphosphate is the predominant product synthesized, smaller amounts of intermediates of intermediates of shorter chain lengths also being produced. The amount of 40-carbon and 45-carbon products relative to 50-carbon products increases as the (2Z,6E)-farnesyl diphosphate concentration is increased, suggesting that the enzyme loses specificity as the substrate concentration increases | ? | |
geranyl diphosphate + isopentenyl diphosphate | - |
Mycobacterium tuberculosis | diphosphate + decaprenyl diphosphate + nonaprenyl diphosphate + octaprenyl diphosphate | decaprenyl diphosphate, nonaprenyl diphosphate, and octaprenyl diphosphate are synthesized. The relative amounts of both decaprenyl diphosphate and octaprenyl diphosphate are greater than that of nonaprenyl diphosphate | ? | |
geranyl diphosphate + isopentenyl diphosphate | - |
Mycobacterium tuberculosis H37Rv | diphosphate + decaprenyl diphosphate + nonaprenyl diphosphate + octaprenyl diphosphate | decaprenyl diphosphate, nonaprenyl diphosphate, and octaprenyl diphosphate are synthesized. The relative amounts of both decaprenyl diphosphate and octaprenyl diphosphate are greater than that of nonaprenyl diphosphate | ? | |
geranylgeranyl diphosphate + isopentenyl diphosphate | - |
Mycobacterium tuberculosis | diphosphate + decaprenyl diphosphate + octaprenyl diphosphate + nonaprenyl diphosphate | the major product synthesized is octaprenyl diphosphate, followed by nonaprenyl diphosphate, decaprenyl diphosphate, and heptaprenyl diphosphate | ? | |
additional information | the enzyme is not strictly specific for either the chain length or stereoconfiguration of the acceptor. No activity with dimethylallyl diphosphate | Mycobacterium tuberculosis | ? | - |
? | |
additional information | the enzyme is not strictly specific for either the chain length or stereoconfiguration of the acceptor. No activity with dimethylallyl diphosphate | Mycobacterium tuberculosis H37Rv | ? | - |
? | |
neryl diphosphate + isopentenyl diphosphate | - |
Mycobacterium tuberculosis | diphosphate + decaprenyl diphosphate + nonaprenyl diphosphate + octaprenyl diphosphate | decaprenyl diphosphate, nonaprenyl diphosphate, and octaprenyl diphosphate are synthesized. The relative amounts of both decaprenyl diphosphate and octaprenyl diphosphate are greater than that of nonaprenyl diphosphate | ? |
Subunits | Comment | Organism |
---|---|---|
? | x * 36000, SDS-PAGE | Mycobacterium tuberculosis |
Synonyms | Comment | Organism |
---|---|---|
Rv2361c | - |
Mycobacterium tuberculosis |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.03 | - |
geranylgeranyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.06 | - |
geranyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.07 | - |
(2E,6E)-farnesyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.08 | - |
isopentenyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.16 | - |
neryl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
11.5 | - |
(2Z,6E)-farnesyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | 8.5 | - |
Mycobacterium tuberculosis |
kcat/KM Value [1/mMs-1] | kcat/KM Value Maximum [1/mMs-1] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.122 | - |
geranyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.75 | - |
geranylgeranyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
0.899 | - |
isopentenyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
5.5 | - |
neryl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis | |
39.66 | - |
(2Z,6E)-farnesyl diphosphate | pH 7.9, 37°C | Mycobacterium tuberculosis |